Journal Article (Letter)

DZNE-2021-01319

http://join2-wiki.gsi.de/foswiki/pub/Main/Artwork/join2_logo100x88.png Validation of Plasma Neurofilament Light Chain as a Marker for α-Synucleinopathies.

Schmitz, M. (First author)DZNE* ; Canaslan, S. (First author)DZNE* ; Villar-Piqué, A.DZNE* ; Gmitterová, K.DZNE* ; Varges, D.DZNE* ; Lingor, P.DZNE* ; Llorens Torres, F. J.DZNE* ; Hermann, P.DZNE* ; Maass, F. ; Zerr, I. (Last author)DZNE*

2021
Wiley New York, NY

This record in other databases:    

Please use a persistent id in citations: doi:10.1002/mds.28724

Keyword(s): Biomarkers (MeSH) ; Humans (MeSH) ; Intermediate Filaments (MeSH) ; Synucleinopathies (MeSH) ; biomarker ; neurofilament light chain ; α-synucleinopathies

---

Contributing Institute(s):

1. Ext UMG Zerr (Ext UMG Zerr ; Ext UMG Zerr)
2. Translational Studies and Biomarkers (AG Zerr)
3. Clinical Dementia Research Göttingen (Clinical Dementia Research Göttingen)

Research Program(s):

1. 353 - Clinical and Health Care Research (POF4-353) (POF4-353)

Appears in the scientific report 2021

---

Database coverage:
; ; ; Clarivate Analytics Master Journal List ; Current Contents - Clinical Medicine ; Current Contents - Life Sciences ; DEAL Wiley ; Ebsco Academic Search ; Essential Science Indicators ; IF >= 5 ; JCR ; Nationallizenz ; SCOPUS ; Science Citation Index Expanded ; Web of Science Core Collection

---